As shown by the remarkable efficacy of molecular-targeted therapies, the IL-23/IL-17 axis, which depends mainly on Th17-cell function, is considered the most essential mechanism of psoriasis (Figure 1) [1,2,10,15,17]. Here, IL17A is linked to psoriasis.